Product image of Latanoprost Viatris (Latanoprost) supplied by GNH India

Latanoprost Viatris

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Viatris (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Viatris, is a prostaglandin F2α analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is indicated for open‑angle glaucoma and ocular hypertension in adults.
GNH India supplies Latanoprost Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Viatris Gx

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latanoprost is a prostaglandin analog used to manage conditions that require reduction of intra‑ocular pressure.

  • Open‑angle glaucoma: lowers intra‑ocular pressure to help prevent optic nerve damage.
  • Ocular hypertension: reduces eye pressure to lower the risk of developing glaucoma.

How It Works

  • Latanoprost binds to prostaglandin F (FP) receptors in the ciliary body, enhancing uveoscleral outflow of aqueous humor. This increased outflow decreases intra‑ocular pressure, helping to protect the optic nerve from pressure‑related damage associated with glaucoma and ocular hypertension.

Side Effects

Latanoprost may cause ocular and peri‑ocular reactions, most of which are mild and reversible.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Increased eyelash growth: longer, thicker lashes.
  • Iris pigmentation: gradual darkening of the iris color.
  • Eye irritation: burning or stinging sensation.
  • Blurred vision: temporary visual disturbance.
  • Periorbital skin darkening: mild hyperpigmentation of skin around the eye.

Serious or Rare Side Effects

  • Uveitis: inflammation of the uveal tract requiring medical attention.
  • Severe allergic reaction: swelling, rash, or difficulty breathing.
  • Ocular inflammation: marked redness, pain, or discharge.
  • Corneal edema: swelling of the cornea affecting vision.
  • Persistent eye pain: may indicate underlying complication.
  • Vision loss: rare but requires immediate evaluation.

Precautions & Warnings

Before using Latanoprost, consider the following safety measures.

  • Pregnancy: safety not established; avoid use unless benefits outweigh risks.
  • Breastfeeding: unknown excretion in milk; consult a healthcare professional.
  • Pre‑existing eye conditions: assess for inflammation or infection before initiation.
  • Concomitant ocular medications: evaluate potential additive effects on intra‑ocular pressure.
  • Contact lens wearers: remove lenses before instillation and wait before reinserting.
  • Store at below 25°C: keep in the original container, protect from light and moisture.

Avoid Interactions

Latanoprost can interact with other ocular agents, influencing efficacy or safety.

Major Interactions (Avoid)

  • Other prostaglandin analogs: additive IOP‑lowering effect may cause excessive pressure reduction.
  • Cycloplegic agents: may diminish Latanoprost’s IOP‑lowering response.

Moderate Interactions (Monitor Closely)

  • Topical corticosteroids: may reduce drug effectiveness.
  • Non‑steroidal anti‑inflammatory eye drops: monitor for irritation.
  • Systemic beta‑blockers: assess overall IOP control when combined with other glaucoma therapies.

Frequently Asked Questions

Latanoprost Viatris is an ophthalmic solution containing the active ingredient latanoprost. It is prescribed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to prevent optic nerve damage and preserve vision.

Latanoprost acts as a prostaglandin F2α analog that binds to FP receptors in the eye’s ciliary body. This binding increases the uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure and decreasing the risk of glaucoma‑related vision loss.

The dosing regimen for Latanoprost Viatris is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and schedule should follow the healthcare provider’s instructions.

Safety of latanoprost in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and a strong IOP‑lowering effect. Compared with beta‑blockers or carbonic anhydrase inhibitors, prostaglandin analogs often have better adherence due to simpler regimens, though individual response and side‑effect profiles may vary.

Latanoprost Viatris should be stored at temperatures below 25 °C, protected from light and moisture. Keep the bottle tightly closed and retain it in its original packaging until use. Do not freeze the solution.

The medication is applied as a single drop into the conjunctival sac of the affected eye(s) once daily, preferably in the evening. Patients should wash their hands before use, avoid touching the tip of the bottle to any surface, and wait a few minutes before applying other eye drops.

Serious but rare risks include uveitis, severe allergic reactions, corneal edema, and significant ocular inflammation. Any sudden eye pain, vision loss, or marked redness should prompt immediate medical evaluation.

Latanoprost is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation. It should also be avoided in individuals with active ocular inflammation or infection until these conditions are resolved.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT